eNOS endothelial nitric oxide synthase
ESRD end-stage renal disease

FFQ food frequency questionnaire

g gram

h hour
HDL high-density lipoprotein
Hg mercury
HHS U.S. Department of Health and Human Services
HR hazard ratio
IHD ischemic heart disease

IOM Institute of Medicine
IS ischemic stroke

K potassium
kg kilogram
KHANES Korean Health and Nutrition Examination Survey

L liter
LDL low-density lipoprotein
LOAEL lowest observed adverse effect level
LVEF left ventricular ejection fraction

mg milligram
MI myocardial infarction
ml milliliter
mm millimeter
mmol millimole

n number
Na sodium
NHANES National Health and Nutrition Examination Survey
NOAEL no-observed adverse effect level

ONTARGET ONgoing Telmisartan Alone in combination with Ramipril Global Endpoint Trial

PRA plasma renin activity
PURE Prospective Urban Rural Epidemiology

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement